EARLY IDENTIFICATION AND MANAGEMENT OF LUNG AND ESOPHAGEAL CANCER

September 16, 2021

This educational program is designed to promote collaboration between oncology and primary care health care professionals to promote optimal care of the patient with cancer. Expert speakers from medicine, will guide participants through updates in cancer screening, discussion on the use of interventional radiology in the management of lung cancer, and side effects of immune checkpoint inhibitors in lung and esophageal cancers.

Learning Objectives

• Identify current screening guidelines for lung and esophageal cancer

• Identify the current evidence based management of lung nodules

• Discuss the role of interventional radiology in the management of lung cancer

• Identify and manage pulmonary side effects from immune checkpoint inhibitors

• Identify the current evidence based management of esophageal cancer

Course summary
Available credit: 
  • 2.00 ACPE - Pharmacist
  • 2.00 AMA PRA Category 1 Credit(s)
  • 2.00 ANCC
  • 2.00 Attendance
  • 2.00 JA Credit - AH
    • 2.00 Approved for AMA PRA Category 1 Credit(s)
Registration Opens: 
09/16/2021
Registration Expires: 
09/15/2022
Activity Starts: 
09/16/2021 - 5:30pm
Activity Ends: 
09/16/2021 - 7:45pm
Rating: 
0
Durham, NC 27705
United States

Available Credit

  • 2.00 ACPE - Pharmacist
  • 2.00 AMA PRA Category 1 Credit(s)
  • 2.00 ANCC
  • 2.00 Attendance
  • 2.00 JA Credit - AH
    • 2.00 Approved for AMA PRA Category 1 Credit(s)
Please login or register to take this course.